The purpose of the PGY2 Infectious Diseases pharmacy residency is to develop and refine clinical, leadership, research management, quality assurance, and teaching skills within the practice of infectious disease. PGY2 residencies provide residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and incorporating both into the provision of patient care or other advanced practice settings. Upon completion of the PGY2 Infectious Diseases Residency, graduates should be well-prepared to pursue board certification (BCIDP) and to enter clinical practice as an infectious diseases clinical specialist, associate or affiliate clinical faculty member, or to pursue infectious diseases fellowship training.
Vanderbilt University Medical Center (VUMC) offers a twelve-month PGY-2 Infectious Disease residency in which residents will gain experience in all areas of ID pharmacotherapy with an emphasis on clinical practice and antimicrobial stewardship. The purpose of the PGY2 Infectious Diseases pharmacy residency is to develop and refine clinical, leadership, research management, quality assurance, and teaching skills within the practice of infectious disease. Upon completion of the PGY2 Infectious Disease Residency, graduates should be well-prepared to enter clinical practice as a distinguished infectious diseases clinical specialist, associate or affiliate clinical faculty member, or to pursue infectious diseases fellowship training.
How to apply
Applicant must be graduated of an accredited Doctor of Pharmacy program, be a licensed pharmacist in any state with reciprocation to Tennessee and completed an accredited PGY1 residency program.
Submit the following application materials for Infectious Diseases Residency to be received by December 31, 2022.
“We provide excellence in healthcare, research and education. We treat others as we wish to be treated. We continuously evaluate and improve our performance.”
The mission of the Department of Pharmaceutical Services is to provide outstanding patient care by optimizing medication use and ensuring patient safety. This commitment extends to our patients, customers & community and encompasses service, teaching and research to optimize medication-related outcomes.
General Residency Information
Vanderbilt University Medical Center has supported post-graduate pharmacy education since 1993 when the PGY1 Pharmacy residency was first accredited by ASHP. Since that time, Vanderbilt has added 4 additional VUMC Adult PGY1 positions and established multiple PGY2 pharmacy residency programs such as: Cardiology (2013), Critical Care (2008), Health System Pharmacy Administration (2016), Infectious Diseases (2017), Informatics (2006), Oncology (2011), Solid Organ Transplant (2006) and PGY1/PGY2 Pediatrics at Monroe Carell Jr. Children’s Hospital at Vanderbilt. All programs at Vanderbilt University Medical Center and Monroe Carell Jr. Children’s Hospi...tal at Vanderbilt are ASHP-accredited or in the accreditation process.
Under the guidance of our clinical and administrative staff our residents have the opportunity to learn and practice pharmaceutical care in acute settings with additional experiences offered in management, critical care, cardiology, oncology, nutrition, transplant, pediatrics, general medicine and informatics. Residents are involved in longitudinal experiences such as conferences, code coverages, research projects, and teaching opportunities, as well as, integrated into multidisciplinary patient teams to optimize pharmacotherapy plans. This unique experience is personally tailored to each pharmacy resident and will build a foundation for the residents to provide a high level of clinical pharmacy practice.
General Program Information
Application deadlines: December 31, 2021
*Please see application website for specific residency application deadlines.